The mission of the International Society of Cardiovascular Pharmacotherapy (ISCP) is to promote and facilitate strategies to improve cardiovascular health through cooperation among cardiac physicians and surgeons, pharmacologists, pharmacists, scientists, and medical practitioners worldwide.
ISCP promotes education, research and evidence-based clinical management in all areas of cardiovascular pharmacotherapy with the ultimate goal of prevention and improving treatment, outcome and patient wellbeing.
ISCP
- Promotes cooperation among individuals, organizations and societies with an interest in CV pharmacotherapy and allied/related disciplines worldwide.
- Sponsors international and regional meetings on CV pharmacotherapy.
- Encourages collaboration among scientists, physicians, surgeons, nurses and health care professionals with an interest in cardiovascular pharmacotherapy. It offers logistic support to scientists wishing to carry out short visits to other institutions with the aim of learning techniques, training on specific pharmacotherapy topics and exchanging research and management ideas.
- Endeavors to stimulate ethical -nondiscriminatory- research programmes, educational activities and pharmacological treatments worldwide. ISCP strongly supports the notion of equal opportunities for individuals of all races and gender, religions, ethnic origins, citizenship, political philosophies or sexual orientation
- Facilitates interactions among cardiovascular physicians, surgeons, pharmacologists and scientists working on related fields under the umbrella of the World Heart Federation and other international bodies such as WHO and UNESCO.
- Promotes the development of novel CV pharmacotherapy techniques and protocols.
- Endorses and develops programmes aimed at increasing public awareness regarding pharmacological treatment issues worldwide, with especial emphasis on issues specific to developing countries.
- Strives to lead on CV pharmacotherapy education at all levels.
- Is committed to endorse research and educational programmes leading to high quality patient care.
- Supports the development of evidence-based, ethical, treatment guidelines which contemplate the specific needs of different regions in the world.
ISCP endorsement of meetings
All individuals, professional societies, federations and associations interested in having programmes considered for endorsement by the ISCP are required to provide us with detailed information regarding the event.
Click here to download the Request for ISCP Endorsement form.
ISCP Executive Board / Board of Directors and other Committees
| President | Juan Carlos Kaski, UK |
|---|---|
| Vice President/President Elect | Gheorghe Dan, Romania |
| Past President | Jay N. Cohn, USA |
| Secretary – Scientific Area | John McNeil, Australia |
| Treasurer | Juan Pascual Mercader, Spain |
Business Manager
Marianne Burle de Figueiredo, Taverna 39, 6575 San Nazzaro, Switzerland
E-mail: marianne.bdf@vtx.ch
President’s Office
Juan Carlos Kaski/Julie Norwood (Secretary), Cardiovascular Sciences Research Centre, St George’s University of London, Cramner Terrace, London, SW17 0RE, United Kingdom.
Email: iscped@sgul.ac.uk
Secretary – Membership area
Cristina Kechichian, UK
E-mail: ckechi@iscpcardio.org
Executive Board/Board of Directors
- A. Bayes de Luna, Spain
- D. Cokkinos, Greece
- E. Escobar, Chile
- D. Hu, China
- M. Kenda, Slovenia
- W.J. Louis, Australia
- F. Martinez, Argentina
- A Matsumori, Japan
- A. Oto, Turkey
- P.M. Vanhoutte, Hong Kong
Emeritus Members
- J. Abrams, USA
- A. Battler, Isreal
- C. Kawai, Japan
- D. Kelly, Australia
- M. Maranhao, Brazil
- L. Opie, South Africa
- R. Paoletti, Hungary
- J.G. Papp, Hungary
- W.J. Remme, The Netherlands
- S. Sasayama, Japan
- A.B.N Singh, USA